Working Memory in Early Alzheimerã¢â‚¬â„¢s Diseasea Neuropsychological Review

Introduction

Yearly, as many as 15% of individuals with mild cognitive damage (MCI) transition into dementia (Huang et al., 2016). Delaying the onset of dementia by a mere 1 year lonely tin can pb to one one thousand thousand fewer cases of incident dementia by 2050 (Zissimopoulos et al., 2014). Working retentivity (WM) deficits are oft constitute in aging individuals, especially in those with MCI or early stages of Alzheimer'due south disease (Huntley and Howard, 2010; Saunders and Summers, 2010). Cognitive training programs within the restorative paradigm is designed for targeting core cognitive functions, including WM. While WM chapters is limited, information technology can be expanded by training, with corresponding changes in neural mechanisms that underly this event (Constantinidis and Klingberg, 2016). Randomized controlled trials bespeak that computerized working memory training (WMT) may improve performance on WM tasks with similar processing demands (Simons et al., 2016). However, studies on computerized cerebral training programs in MCI individuals showed mixed results, only some studies showed benefits on cognition, and the transfer effects to non-trained tasks were inconclusive (Belleville et al., 2006; Rozzini et al., 2007; Talassi et al., 2007). The heterogeneity within the MCI population, due to various underlying encephalon pathology or co-morbid conditions, likewise might have contributed to the various findings on training effects of cognitive interventions in MCI patients.

Dopamine is involved in various brain functions, including arousal, motivation and college executive functions. Dopaminergic part is also essential to cognition past regulating attending and mediating WM function (Goldman-Rakic, 1996a; Salami et al., 2019), equally well equally motor function and processing speed (Eckart and Bunzeck, 2013). All the same, both dopamine transporters and receptors, hence the dopaminergic synapses, decline with normal aging (van Dyck et al., 1995; Karrer et al., 2017), and in those with MCI, leading to psychomotor slowing, working memory deficits and parkinsonism in some individuals (Sasaki, 2018). Dopaminergic synapses hold a fundamental role in plasticity (Söderqvist et al., 2012), and the loss of dopaminergic receptors is believed to be responsible for many adverse effects of cerebral aging (Li et al., 2010). The Lim homeobox transcription factor 1 alpha (LMX1A) gene is involved in the production, differentiation and preservation of dopaminergic neurons in the midbrain and is necessary for the brain's development and maintenance of dopaminergic neurons. The association of allelic frequencies of the LMX1A and neurological diseases has been studied only to a express extent (Bergman et al., 2010; Rolstad et al., 2015). For example, LMX1A-AA carriers with HIV-associated neurocognitive disorders showed greater WM grooming gain than non-carriers (Chang et al., 2017), whereas conflicting results be in cognitively normal individuals (Bellander et al., 2011, 2015).

Likewise age, apolipoprotein E (APOE) is i of the most studied factors associated with cognitive decline. APOE carries phospholipids and cholesterol within the trunk and plays a major function in neuronal cholesterol metabolism and synaptogenesis. The APOE-ε4 allele has meaning influence on cerebral role, and APOE-ε4 homozygosity is the strongest known single risk factor for late onset Alzheimer's dementia. Individuals with APOE-ε4 have reduced synaptic plasticity (Arendt, 2009) and peradventure impaired cognitive trainability. While individuals at younger or middle ages showed positive effects, those older than 65 years of historic period typically showed negative effects of the APOE-ε4 allele on cognitive performance (Chang et al., 2011); nonetheless, greater lifetime levels of cognitive activities seem to attenuate these negative effects (Wirth et al., 2014).

This sub-study of the Memory Aid study (Flak et al., 2014) investigated the furnishings of computerized WMT in patients with amnestic (aMCI) and non-amnestic MCI (naMCI). As a pilot study, we additionally explored the modulatory effects of allelic variations in APOEε and LMX1A on the WM training outcomes. Since individuals with meliorate WM capacity showed amend cognitive training efficacy (Matysiak et al., 2019), we hypothesized that: (1) individuals with naMCI, who likely would accept better WM capacity (Constantinidou et al., 2014), would display amend cerebral performance and greater preparation effects, than those with aMCI; (ii) based on the greater training effects in those with LMX1A-AA, both in healthy individuals (Bellander et al., 2011) and in those with a degenerative encephalon disorder (Chang et al., 2017), nosotros also expected our MCI participants with LMX1A-AA genotype to show greater training furnishings than non-carriers; (3) based on the better cognitive performance in younger and middle age individuals with APOE-ε4 allele (Chang et al., 2011; Zink et al., 2019), we farther expected our MCI participants (boilerplate age in the 60s) with at least ane copy of this allele to show better training furnishings.

Materials and Methods

The Norwegian Regional Commission for medical and health enquiry ideals, Southward-Eastern region (2013/410) approved the report (clinicaltrials.gov NCT01991405). Written informed consent was obtained from each participant before report initiation. The data presented in this paper is a substudy of the Retention Assistance study as described in the published protocol (Flak et al., 2014).

Participants were recruited from iv Norwegian retention clinics and included in the study only if they fulfilled these inclusion criteria: (one) prior diagnosis of MCI within the terminal xv months. The Petersen/Winblad criteria for MCI (Winblad et al., 2004) were used for diagnosis, every bit specified by the guidelines from the Norwegian registry of patients assessed for cognitive symptoms (NorCog). The assessment included neuropsychological tests, and questionnaires for observation of risk factors. (2) Their willingness to complete the 20–25 session of WMT plan and the follow-up evaluations. The participants were excluded from the study if they had any of these conditions: (1) any psychiatric conditions including depression; specifically, none of the participants had moderate or severe depression co-ordinate to their pre-trial screenings; (2) history of significant brain disorders (e.g., stroke or epilepsy); (three) use of any type of dementia-delaying medication; (four) head trauma with post-traumatic loss of consciousness for at least 30 min during the lifespan; (5) loss of senses that might confound the training effects (e.g., blindness, deafness); (half-dozen) individuals with contraindications for magnetic resonance imaging (e.thou., implanted metallic foreign objects or severe claustrophobia), which was needed to exclude those with significant MRI lesions (e.chiliad., prior strokes, tumors).

Socioeconomic status (SES) was assessed with Hollingshead's index of instruction and occupational position, scaled from one (low) to five (high) (Hollingshead and Redlich, 2007).

Working Memory Training (WMT)

The participants were randomized to 20–25 session/4 weeks of either adaptive or non-adaptive WMT using Cogmed^® RM (Pearson instruction, Inc.). The concrete advent of the cognitive training program is identical in the two versions of the plan. In the adaptive version, the tasks became increasingly complex and hard equally the individual mastered each level, making the participant work at his or her maximum chapters at all times (i.e., adaptive training). In the non-adaptive version, the participants trained at a fixed low level of difficulty, with a span of 3 or fewer items per job. The training is described in detail elsewhere (Flak et al., 2019). However, since we did non find grouping differences in the two types of training, and we have a limited sample size, we combined the participants who had the two grooming types into one group for each of the MCI subtype groups. Since the adaptive preparation would require the participants to main each level before they avant-garde to the next more difficult level, the lack of group differences in the adaptive versus non-adaptive training suggest that those who performed the adaptive training might have stayed at similarly low levels as those who performed the stock-still lower level training.

Neuropsychological Cess

The participants were assessed with neuropsychological tests at iii time points: at baseline (T0), four weeks afterward preparation (T1) and 16 weeks after preparation (T2). The cognitive evaluation included the administration of standardized and commonly used neuropsychological tests (Wechsler Retentivity Scale third edition/WMSIII, Delis–Kaplan Executive Function System/D-KEFS, California Verbal Learning Test 2nd edition/CVLT-2, and Rey Complex Effigy Test/RCFT). The tests were grouped into nine cognitive domains. Theoretical framework, clinical do and research studies practise not provide consensus on how neuropsychological tests should exist clustered. Due to our small sample size, using cistron analysis to cluster the tests into cognitive domains was not feasible. The tests were thus grouped into nine cerebral domains based on Rog and Finks recommendations for evaluating MCI (Table 1) (Rog and Fink, 2013). For Digit span, California Verbal Learning Test-II and Exact Fluency alterative versions of the tests were used at each time-point to minimize practise effects. In order to compare cerebral performance across the domains, Z-scores were calculated based on the group operation at baseline as described elsewhere (Flak et al., 2019).

Table 1. Assessed cognitive domains and respective neuropsychological tests.

Classification of Amnestic and Non-amnestic MCI Subtypes

Classification of the MCI subtype was performed after inclusion, co-ordinate to the patient's cognitive profiles at baseline. Individuals with scores more than −one.5 SD from the hateful compared to norms on the delayed exact and/or visual episodic memory were classified into the amnestic MCI (aMCI) group. Those with normal scores in the memory domains, combined with scores more −i.five standard departure from the mean in one or more of the other domains assessed, were categorized into the not-amnestic MCI (naMCI) group (Petersen et al., 1999; Winblad et al., 2004).

Genotyping/DNA Collection

Deoxyribonucleic acid was extracted from saliva collected in Oragene Self collection Kit (DAN Genotek, Inc., Ottawa, ON, Canada). Genomic DNA was analyzed with Restriction Fragment Length Polymorphism (RFLP-PCR) for genotype analyses of APOEε (rs429358 and rs7412) and LMX1A (rs4657412), as reported previously (Chang et al., 2016, 2017). Specifically, for LMX1A, genomic Deoxyribonucleic acid were amplified by PCR using the primers LMX-five′:v′-CTCGCCTCCAGGAA TGGGTGTTGTA-3′ and LMX-3′: 5′-GCCACGAGGAACTTGTGAGAGGGTT-iii′ for LMX1A, and APO-5′ and APO-3′ for APOEε. The amplifications were performed on the denatured Dna (94°C for 5 min, thirty cycles at 94°C, annealed at 64°C for xxx south, and extending at 72°C for 30 s). The amplified PCR products were and then digested with three restriction enzymes sequentially overnight at 37°C. The digested PCR products were then evaluated on 4% agarose gel and visualized using GelGreen^TM Nucleic Acid Gel Stain (89139–144, Biotium, Hayward, CA, The states).

Statistical Assay

Statistical analyses were performed with R version 3.5.ii. Since no group differences on the training effects were found at baseline betwixt the non-adaptive and adaptive WMT groups (Flak et al., 2019), the data from these two grooming groups were pooled and analyzed equally one training grouping. The sample size and ability calculations were based on the primary upshot of the Memory Aid written report with differences in preparation gains betwixt the adaptive and non-adaptive WMT equally reported (Flak et al., 2019). Imputation was performed for two datapoints, for one subject at 4-week post training, and another at 16 weeks post training, using 'missForest' in R.

A weighted-general interpretation model (WGEE) was used, with training (across baselineT0, T1, T2), genotype (LMX1A with AA or AG/GG; APOE with ε4 or Non-ε4), and MCI subtype (aMCI or naMCI) as main effects. Sex, historic period at baseline, SES, and education were included as covariates. Age and sex activity were removed from the terminal model when no significant effects from these variables were plant. Possible interactions between the training effect^∗genotype, training^∗MCI subtype, MCI subtype^∗genotype and training^∗MCI subtype^∗genotype, were also evaluated. Postal service hoc analyses were performed past the used of paired t-tests, comparison either the results at 4 weeks post-training to baseline (T1 vs. T0), sixteen weeks post-grooming to baseline (T2 vs. T0), or T2 vs. T1. For all analyses, since we had a priori hypotheses, p-values < 0.05 was considered significant, simply we additionally calculated the Benjamini-Hochberg false discovery rate (FDR), with a Q-value fix at 0.05, to appraise for those that remained significant.

Results

As shown in Figure 1, although 491 participants were eligible for recruitment form these clinics, merely 85 participants were recruited from the 4 centers in the Retentivity Aid study and provided initial consents to be in the study. Of these 85 participants, 11 individuals changed their minds and withdrew from the study prior to initiating the Cogmed training, leaving 69 (72%) individuals who completed the cerebral preparation. Blood samples were collected from 63 individuals who provided the additional consents required for the genotyping, but usable genetic data were available only from 61 of these individuals (Figure one). But one individual missed the T1 follow-up evaluation, and one private missing the T2 visit. Based on the screening evaluations and the in-person baseline and follow-up cognitive and neuropsychological evaluations, none of the participants in the current study had moderate or severe depressive symptoms. Run into Table 2 for the baseline characteristics of the participants.

Effigy 1. Overview of study population in the retentiveness aid study.

Table 2. Participant characteristics, LMX1A genotype, APOE epsilon (ε) allele, and baseline cerebral performance.

MCI Blazon Effects

At baseline, the aMCI and the naMCI groups had like age, sex, years of pedagogy, race-distribution, SES, and the proportion with the LMX1A-AA genotype or the APOEε4 allele (type effects, Table two). The training blazon allocation were equally divided betwixt MCI subtype (χⁱⁱ = 0.52). The two MCI subgroups also showed similar proportion of participants with the combined genotypes of LMX1A-AA and APOEε4 allele. Across all MCI participants, 52.5% had single domain cognitive deficits; however, majority (74.2%) of the aMCI group had multidomain deficits while 80% of the naMCI grouping had single domain deficits. Therefore, every bit expected, the ii MCI-subtype groups differed significantly in all cognitive domains, except for WM, Processing Speed, and Verbal Memory recognition. While the aMCI group performed beneath the mean, the naMCI group performed slightly above the hateful in all domains. Hence, except for Processing Speed, the naMCI performed amend than the aMCI group in all domains at all time points (Tables 2, three, MCI Type Effect). Regarding the WM training type performed, the proportion for each grooming blazon were non different between the two MCI groups (aMCI group: 16 had the non-adaptive (stock-still level) and 15 had the adaptive training; naMCI grouping: xiii received the not-adaptive (stock-still depression level) and 17 had the adaptive grooming). The two training types were combined since they showed no difference in the training effects.

Table iii. Visit effects, MCI type effects, and visit*MCI type effects beyond all subjects.

Training Furnishings

Private preparation effects in this report were defined as changes in cognitive scores in each domain as compared to baseline. Significant training-related improvements were found in WM, and trends for training furnishings on Processing Speed and Verbal_Memory_Long-Filibuster domains across all subjects (Training Issue, Table iii). Post hoc analyses and Table 3 showed that, compared to T0, significant improvement was observed in the WM domain at T1 for both the aMCI group (+0.33; p = 0.004) and for the naMCI group (+0.43, p < 0.00001), simply only the naMCI group maintained the improvement (T2 vs. T0: +0.24%, p = 0.05). Nonetheless, in the Processing Speed domain, both groups showed slight declined in performance afterward WMT, and the aMCI grouping showed significant decline at T2 (−0.11; p = 0.005).

Furthermore, the naMCI group showed greater training effect than the aMCI group (training^∗MCI blazon, Tabular array iii) in the Attention (p = 0.002) and Executive Function (p = 0.0003) domains. Post hoc analyses showed these group differences were due to the significant comeback in the Attending domain simply in the naMCI group at T2 (+0.26; p = 0.003), merely meaning reject in the Executive function domain just the aMCI group at both T1 (−0.14; p = 0.004) and T2 (−0.19; p = 0.002).

LMX1A Genotype Effect

A LMX1A genotype effect was found in the Verbal_Learning_Short-Filibuster domain (p = 0.016); within each MCI subtype, those with LMX1A-AA genotype had lower operation across all timepoints (Figure 2A). Even so, in this aforementioned domain, a 3-manner interaction (preparation^∗MCI type^∗LMX1A, Table four) showed that those with LMX1A-AG/Thousand had improved performance at T1 if they were naMCI, but declined function if they were aMCI subtype. Furthermore, two-way interactions (MCI type^∗ LMX1A) were institute in the Visual_Memory_Long_Delay and the Visual Learning_Short_Delayed domains (Figures 2B,C). In both of these domains, the naMCI group with LMX1A-AA had higher z-scores than the aMCI group beyond all time points.

Figure 2. Group comparisons (MCI type and LMX1A genotype) of cerebral performance between baseline, 4 and 16 weeks later working memory preparation (WMT). (A) In the Verbal_Learning_Short_Delay domain, the non-amnestic MCI (naMCI) grouping performed better than the amnestic MCI (aMCI) group (MCI type, p = 0.000). The LMX1A-AA carriers, regardless of MCI type, consistently had lower scores across all timepoints (Visit*MCI type* LMX1A, p = 0.008). (B) In the Visual_Memory_Long_Delay domain, the naMCI group also tended to perform improve than the aMCI group (MCI blazon, p = 0.000). The naMCI group with LMX1A-AA also tended to take higher z-scores than the aMCI grouping across all time points (MCI type*LMX1A, p = 0.047). Pairwise comparisons inside each group revealed significant improvement at T1 compared to T0 (p = 0.043) in the naMCI-LMX1A-AA group and at T2 compared to T0 in the aMCI-LMX1A-AG/GG grouping. (C) In the Visual_Learning_Short_Delay domain, the naMCI group performed better than the aMCI group (MCI blazon, p = 0.000), and the naMCI grouping with LMX1A-AA had higher z-scores than the aMCI group across all fourth dimension points (MCI type*LMX1A, p = 0.022), with significant improvement at T2 compared to T0 (p = 0.014). P-values are from the changed proportional weighting, using the generalized estimating equations (GEE) method (run into "Statistical Assay" section for details).

Tabular array 4. Visit effects, MCI blazon effects, LMX1A genotype (AA vs. AG/GG) effects and interaction effects across groups.

APOE-ε Allele Effect

Consistent with findings higher up, regardless of APOE-ε4 allele, naMCI patients consistently performed better on all domains across the time points than aMCI patients (MCI Type Effect, Table 5). Nevertheless, regardless of MCI type, patients with APOE-ε4 allele tended to performed ameliorate on four cognitive domains than those without APOE-ε4: WM (p = 0.031), Attention (p = 0.019), Processing Speed (p = 0.049) and Visual Retention long_delay (p = 0.013) (Tabular array five and Figures 3A–C, data not shown for Processing Speed). Furthermore, a training^∗ APOE-ε4 genotype interaction was found for Visual_Memory_Long_Delay (p = 0.025); APOE-ε4 individuals showed improved functioning later on training, merely not those without the APOE-ε4, regardless of MCI subtype (Figure 3C). Lastly, a 3-fashion interaction between WMT^∗MCI type^∗ APOE-ε4 genotype was observed for the Executive Function domain (p < 0.0001, Table 5). Specifically, at 16 weeks subsequently Cogmed training (T2), while the naMCI patients with APOE-ε4 showed improvement in Executive Function (T2 vs. T0, p = 0.019), aMCI patients with APOE-ε4+ showed declined in this domain (T2 vs. T0, p = 0.028), Figure 3D. Thursday-is 3-mode interaction for Executive Functions remained significant after FDR correction (Table five).

Table 5. Visit effects, MCI type furnishings, APOE-epsilon allele (ε4 vs. non-ε4) effects and interaction effects across groups.

Figure iii. Group comparisons (MCI blazon and APOEε genotype) of cognitive functioning betwixt baseline, 4 and 16 weeks subsequently working retentivity grooming (WMT). (A) In the Working Memory domain the APOE-ε4 carriers (cerise lines) performed ameliorate than the non-carriers (blue lines); APOEε4 genotype, p = 0.031. Post hoc analyses showed that both the naMCI groups improved at T1 compared to T0 after WMT (APOE-ε4: p = 0.006; non-APOE-ε4: p = 0.0023). (B) In the Attending domain the naMCI groups (dotted lines) performed improve than the aMCI groups (solid lines) at all timepoints regardless of APOE-ε4 wagon (MCI blazon, p = 0.019). Furthermore, the naMCI subjects improved further at T2 (compared to T1 for APOE-ε4: p = 0.05; compared to T0 for APOE-ε: p = 0.002). (C) In the Visual Memory Long Delay domain the APOE ε4 groups (red) performed better than the groups without the APOE ε4 (blue) across all time points (APOE ε4 Genotype, p = 0.013), and the APOE ε4-carrier groups also showed greater training effects than the groups without the APOE ε4 (APOE ε4 genotype*training: p = 0.025; red lines). Postal service hoc analyses showed that both APOE-ε4 carrier groups improved further at T2 (T2 vs. T0: naMCI: p = 0.007; aMCI p = 0.008). (D) In the Executive Function domain, the naMCI group performed improve than the aMCI group across all time points, and the APOE ε4 grouping showed greater training issue only if they were also naMCI subjects (MCI type*training*APOEε4 genotype, p < 0.0001). Post hoc analyses demonstrate this at 16 weeks after Cogmed training (T2), while the naMCI patients with APOE-ε4 showed improvement in Executive Office (T2 vs. T0, p = 0.019), aMCI patients with APOE-ε4 showed declined in this domain (T2 vs. T0, p = 0.028). The aMCI-APOE-ε4 showed declined even at 4 weeks after WMT (p = 0.013). P-values are from the inverse proportional weighting, using the generalized estimating equations (GEE) method (see "Statistical Analysis" section for details).

Discussion

The main findings of the present study are: (one) The naMCI grouping performed better in majority of the cognitive domains compared to the aMCI group at baseline. (2) All participants showed improved cognitive performance on several domains (Working Retentivity, Processing Speed, and Verbal_Memory_Long_Delay) afterward WM grooming. The naMCI group showed greater training effects than the aMCI group on Attention and Executive function. After 16 weeks, the naMCI group was able to maintain their preparation gains in WM and showed further improvement in Attention, while the aMCI grouping showed pregnant decline in these domains. (3) For the LMX1A genotype, naMCI patients with AA genotype had better training furnishings than those with AG/GG genotypes on Verbal_Learning_Short_Delay and Visual_Learning_Short_Delay. (4) Our participants tended to bear witness better cerebral performance in WM, Attending, Processing Speed, and Visual_Memory_Long_Delay simply if they were APOE-ε4 carriers. Lastly, only those with naMCI and the APOE-ε4 carriers showed improved Executive Function afterwards 16 weeks of grooming. Collectively, these findings demonstrate how the subtype of MCI, and their LMX1A genotype or presence of APOE-ε4 allele, may influence cerebral training outcomes, which would exist important in designing the optimal training plan for individuals with these different genotypes.

The poorer cognitive operation in the aMCI grouping compared to the naMCI group is consistent with previous enquiry (Petersen et al., 1999, 2017; Jack et al., 2016; X Kate et al., 2017). Patients with aMCI as well showed much greater prevalence of positive amyloid PET imaging (with carbon-11-Pittsburgh compound B), and were more likely to progress to Alzheimer's affliction dementia compared to naMCI patients (Oltra-Cucarella et al., 2018; Jimenez-Bonilla et al., 2019). These findings suggest that the level of neural plasticity or cognitive reserve might be reduced with disease progression and increasing amyloid deposition in the aMCI patients only relatively preserved or less affected in naMCI patients. Therefore, although all participants in this study showed improved WM and Verbal_Memory_Long_Delay later on the Cogmed training at the i-month follow-up, only the naMCI group maintained their grooming gain in WM and further improved on Attention at 16 weeks, while the aMCI subjects showed continued decline in Attention and in Processing Speed at follow-ups. The improved WM afterward Cogmed grooming is similar to previous studies (Belleville et al., 2006; Rozzini et al., 2007; Talassi et al., 2007), while the improved Verbal_Memory_Long_Delay represents a transfer of training effect to a non-trained domain. The greater decline in Processing Speed in the aMCI grouping than the naMCI grouping might also be viewed every bit a disease marking, possibly linked to reduced connectivity based on impaired neural and white matter integrity (Park and Reuter-Lorenz, 2009).

At xvi weeks after training, the naMCI groups showed significant improvements in Attending and Executive Office, while the aMCI group showed progressive pass up in Executive Office. Attentional abilities correlated with independent living in aMCI, but not in naMCI (Putcha and Tremont, 2016). Our findings in the naMCI patients are consistent with those in MCI patients with small-vessel disease who showed improved attention and executive office afterwards a targeted training in attending (Pantoni et al., 2017). Furthermore, the higher baseline cognitive role in the naMCI grouping likely contributed to the greater preparation furnishings since they might have more cognitive reserve and neuroplasticity. Although our aMCI group did not evidence comeback in Attention, they remained stable for the duration of the study, which may reflect a type of preparation effect to remain stable, given their likely reduced cerebral reserve and neural plasticity. Another study of MCI patients that focused on "executive attention" training found comeback only in selective attention (Digit Span Chore, same job as in our WM domain) (Yang et al., 2019), without transfer furnishings to "focused attention" (Stroop Color Word Exam, same as in our Executive Function domain). However, their study population were older which might take impacted the results. They also did not split up the MCI patients into aMCI and naMCI which might have confounded their findings.

Another variable that might influence the training effect or group differences in the baseline cognitive operation is the polymorphism of the dopaminergic gene LMX1A, since those with the AA genotype showed greater training effects than those with the AG/GG genotypes after WM preparation, both in healthy individuals (Bellander et al., 2011) and in those with HIV-infection (Chang et al., 2017). In dissimilarity to these earlier studies, we did not detect greater preparation effects in WM; instead, only naMCI patients with LMX1A-AA showed greater preparation gains in Exact Learning Short_Delay, and trends for greater grooming effects in Verbal Retentiveness and Visual Learning domains as well. The LMX1A cistron encoded protein is a transcription cistron that regulates insulin gene transcription, and maintains mitochondrial function in midbrain dopaminergic neurons (Doucet-Beaupre et al., 2016). Hence, this essential protein maintains the survival of dopaminergic neurons, which are involved not merely in motor function, just also in motivation, learning and retentivity. Dopaminergic receptors mediate WM (Goldman-Rakic, 1996b) and those with LMX1A-AA genotype showed greater improvement and neural efficiency after Cogmed training (Chang et al., 2017). However, recent data demonstrated that dopaminergic role may likewise impact hippocampal memory processes (Chowdhury et al., 2012) with less specific retentiveness retrieval in older adults due to the dedifferentiation of cerebral aging (Abdulrahman et al., 2017). Since verbal learning is thought to exist a sensitive marker for progression from memory impairment to dementia (Bondi and Smith, 2014), the trainability of this domain might exist an important target for farther research. In our study, we were only able to find a grooming proceeds for exact learning in the naMCI LMX1A-AA group 1-month after WM training. Lastly, like to our report, carriers of the val allele of the COMT Val¹⁵⁸Met polymorphism, another gene that regulates the dopaminergic system, also showed lower baseline functioning but greater plasticity of working memory (Bellander et al., 2015), and showed greater WM training-related prefrontal plasticity (Zhao et al., 2020). Future studies should include the evaluation of COMT polymorphism.

Another consideration is the prevalence of the LMX1A-AA genotype in each of the MCI subgroups. The LMX1A-AA allele for the rs4657412 SNP in our current study is sixty.6% for the total sample, 67.vii% for the amnestic MCI group and 53.three% for the non-amnestic MCI group (Table 2), which are like to this allelic frequency in the full general population from ii Swedish cohorts that showed the frequencies of 54.2 and 61.8% (Bergman et al., 2010; Rolstad et al., 2015). In Parkinson's disease, the allelic frequency of the A allele for the rs4657412 SNP was 24%, which was marginally higher than the controls at 20.seven% (Bergman et al., 2009). Despite the slightly increased prevalence of the LMX1A-AA genotype in the aMCI group (67.7%) than the naMCI group (53.3%), they did not benefit from having this genotype and showed a poorer WMT effect than the naMCI grouping. Furthermore, polymorphism of APOE genotype may influence the training outcomes. APOE is a poly peptide required for trophic support, programmed cell death, microtubule disassembly, synaptic function, aging, and insulin resistance—all processes that have been implicated in AD pathogenesis (Theendakara et al., 2018). APOE-ε4 carrier status was associated with greater memory harm in analyses that co-varied for duration of disease (Smith et al., 1998). In studies that combined AD dementia and MCI, ε4 homozygosity was associated with poorer memory, learning, and verbal comprehension at a given disease duration (Smith et al., 1998). The progression from MCI to Ad was also found to be faster in homozygotic carriers than in the carriers of one or no APOE-ε4 allele (Tuminello and Han, 2011). Currently, no known knowledge exists whether targeted cognitive interventions may do good those with increased genetic take chances of cognitive impairments. However, in the electric current study, APOE-ε4 carriers tended to perform better on WM, Attention, Processing Speed and Visual Memory Long_Delay, and just the APOE-ε4 carriers, regardless of MCI type, showed improvements in the Visual Memory-Long Delay domain after the Cogmed preparation. These findings are consistent with the antagonistic pleiotropy effects of APOE-ε4, since our MCI patients are relatively younger than the typical Advert patients, and may still be able to utilize their cogntive and neural reseve (Tuminello and Han, 2011; Chang et al., 2016). Compared to the typical Alzheimer's disease (Advertizing) patients, our MCI patients were relatively younger; differences in historic period likely contributed to these diverging results on the effects of APOE-ε4 on cerebral functioning. Since those with LMX1A-AA genotype or APOE-ε4 allele showed better cognitive outcomes afterward the WMT, nosotros might expect individuals with both of these genotypes to show the all-time outcomes. Still, given the pocket-size sample sizes and similar proportion of this combination in either the aMCI (n = 7) or naMCI (n = 8) group, we could not determine this possible event. A future larger written report is needed to evaluate whether this combination would atomic number 82 to the strongest training effects, or would modulate the preparation effects differently in aMCI versus naMCI patients.

Furthermore, over the follow-up period of nigh half dozen months (from baseline to xvi weeks after the Cogmed training), the opposing effect from disease progression might hide additional training gains specially in the aMCI carriers. The APOE-ε4 carriers may be able to recoup more than, both in magnitude and extent in neuronal activation, than the non-carriers by recruitment of their junior frontal gyrus in the prefrontal cortex during challenging WM tasks (Scheller et al., 2017). In the Executive Function domain, the naMCI APOE ε4-carrier group showed a significant improvement after 16 weeks, whereas the aMCI APOE ε4-carrier group showed significant pass up. This disparate result might be due to the greater underlying amyloid deposition and possibly lesser cerebral reserve in the aMCI patients, compared to those with naMCI.

Limitations

Despite the encouraging findings in the current study, several limitations should be considered to better future studies in patients with MCI. Start, the sample size for each of the subgroups is relatively small, especially when the modulating effects of the genotypes on complex traits such as cognitive functions are investigated. Given the small sample in the subgroups, these findings must be interpreted with circumspection and should be considered preliminary to guide future larger validation studies. Furthermore, although we would expect that the naMCI participants who had the combined genotypes of LMX1A-AA and APOE-ε4 would perform fifty-fifty better than those without this combination of genotypes after the WM training, the samples size was too pocket-sized for us to draw whatsoever conclusions and volition need to be investigated in a future larger study, Second, the written report participants are mainly of Scandinavian descent, which minimized the genetic heterogeneity, merely the findings may not be generalizable to other racial groups. For instance, racial disparity exists for dementia and the hazard gene APOE-ε4 doubles the take chances for dementia amongst whites with no increase amidst blacks (Weuve et al., 2018). Third, the participants in the current study had twice as many men than women, which is non typical for individuals with MCI or AD. One reason for the greater proportion of men than women in our study might be the fact that more men used computers than women in these regions of Norway, and thus were more probable to participate in this computer-training study. Therefore, our findings may non be generalizable to the typical MCI population. Time to come larger studies demand to enroll a representative sexual practice-proportion of individuals with MCI. 4th, a pick bias in "help-seeking" attitudes might be present inside the study population, as the participants were recruited from the retention clinics and were mainly well educated and motivated to amend their cognition.

Nevertheless, a major strength of our study is the use of a well-divers MCI definition from a Retentiveness dispensary sample, which also minimized the variability in the study sample. Furthermore, all patients were assessed past the same experienced neuropsychologist, which eliminated the inter-tester variability. The efficacy of computerized cognitive grooming in MCI patients is debated (Sherman et al., 2017), mostly due to variable results, poor scientific quality on some studies and commercial marketing that promise benefits to multiple cerebral domains. Our study finds transfer furnishings in some not-trained domains later on WM training but not in all. No consensus identifies the cognitive domains where restorative interventions will have the largest impact on daily life function in MCI patients. This knowledge gap needs to be identified in order to individualize a targeted intervention. WM training in individuals with MCI might be an effective intervention to delay the onset of dementia by increasing the compensatory, neuroplasticity abilities (scaffolds), past targeting WM specifically and cognitive reserve generally. Longitudinal studies that follow MCI patients after cognitive (WM) training is needed to evaluate this possibility.

Clinical Implications

Currently, no curative or memory restoring interventions exists for individuals with MCI. This study shows preliminary show for different effects of WMT that are dependent on MCI subtype, and on the genetic polymorphisms of two of genes. WMT in the naMCI patients showed promising results.

The effects of the LMX1A and APOE genes follow complicated patterns across the life span, depending on interactions with other genes and background factors. Clinically, a stable and maintained performance in cognitive function over time might reverberate an actual training gain since some of the participants might take ongoing neuropathological progression that counteract the furnishings of training. Future larger and longitudinal studies are needed to validate our findings, and to determine the long-term outcomes.

Conclusion

Working memory training may amend cerebral function, both for WM and other non-trained domains. Our data point that the MCI subtypes and the genotypes may both influence grooming furnishings. Carriers of the APOE-ε4 allele showed positive cerebral furnishings from the intervention regardless of the subtype, which propose that these relatively younger MCI patients notwithstanding have adequate cerebral reserve or neural plasticity. Therefore, cognitive training programs should consider the MCI subtype, likewise as the individual's genetic data, to facilitate a more personalized training approach.

Data Availability Argument

The datasets presented in this article are not readily available because The Norwegian Regional Commission for medical and health research ethics limit data sharing, and de-identified data tin can only exist shared afterwards an application process. The study protocol is publicly available. The statistical analysis plan is bachelor upon request past members of the academic customs for the next five years. The generated datasets are bachelor by request to the corresponding authors. Requests to access the datasets should exist directed to SH, Susanne.sorensen.hernes@sshf.no.

Ethics Statement

The studies involving man participants were reviewed and canonical past The Norwegian Regional Committee for medical and health research ethics, Southward-Eastern region (2013/410) approved the report (clinicaltrials.gov NCT01991405). The patients/participants provided their written informed consent to participate in this report.

Writer Contributions

SH, MF, GL, JS, and LC conceptualized and designed the study. MF, GL, AE, AP, IU, B-OM, A-BK, TL, and HH nerveless the data. SH, MF, XZ, and LC analyzed the information. SH, MF, HH, GL, JS, and LC interpreted the information. SH, MF, GL, XZ, and LC drafted the commodity. All authors have critically revised the article and approved the final version of manuscript to be published.

Funding

This study was funded past a research grant from the South Eastern Norway Regional Health Authority (2013059) and by the Fulbright Norway Foundation (fe7e0da15bfc05ab6e075c6f97cfb65c). Dr. Chang'due south try was supported past the University of Maryland, School of Medicine, and the John A. Burns School of Medicine at the Academy of Hawai'i at Mānoa.

Conflict of Interest

The authors declare that the research was conducted in the absence of whatsoever commercial or financial relationships that could be construed as a potential disharmonize of involvement.

References

Abdulrahman, H., Fletcher, P. C., Bullmore, E., and Morcom, A. M. (2017). Dopamine and memory dedifferentiation in aging. Neuroimage 153, 211–220. doi: 10.1016/j.neuroimage.2015.03.031

PubMed Abstract | CrossRef Full Text | Google Scholar

Arendt, T. (2009). Synaptic degeneration in Alzheimer's disease. Acta Neuropathol. 118, 167–179.

Google Scholar

Bellander, K., Bäckman, 50., Liu, T., Schjeide, B.-M. Thou., Bertram, L., Schmiedek, F., et al. (2015). Lower baseline performance simply greater plasticity of working retention for carriers of the val allele of the COMT Val${}_{58}^{\mathrm{one}}$Met polymorphism. Neuropsychology 29, 247–254.

Google Scholar

Bellander, Yard., Brehmer, Y., Westerberg, H., Karlsson, S., Fürth, D., Bergman, O., et al. (2011). Preliminary show that allelic variation in the LMX1A factor influences training-related working retention improvement. Neuropsychologia 49, 1938–1942. doi: 10.1016/j.neuropsychologia.2011.03.021

PubMed Abstract | CrossRef Total Text | Google Scholar

Belleville, Southward., Gilbert, B., Fontaine, F., Gagnon, L., Ménard, É, and Gauthier, S. (2006). Improvement of episodic memory in persons with mild cognitive impairment and healthy older adults: evidence from a cognitive intervention plan. Dement. Geriatr. Cogn. Disor. 22, 486–499. doi: 10.1159/000096316

PubMed Abstract | CrossRef Total Text | Google Scholar

Bergman, O., Håkansson, A., Westberg, L., Belin, A. C., Sydow, O., Olson, L., et al. (2009). Exercise polymorphisms in transcription factors LMX1A and LMX1B influence the take a chance for Parkinson's affliction? J. Neural Transmis. 116, 333–338. doi: 10.1007/s00702-009-0187-z

PubMed Abstract | CrossRef Full Text | Google Scholar

Bergman, O., Westberg, 50., Nilsson, 50.-G., Adolfsson, R., and Eriksson, Due east. (2010). Preliminary evidence that polymorphisms in dopamine-related transcription factors LMX1A, LMX1B and PITX3 are associated with schizophrenia. Progr. Neuro Psychopharmacol. Biol. Psych. 34, 1094–1097. doi: 10.1016/j.pnpbp.2010.05.032

PubMed Abstract | CrossRef Full Text | Google Scholar

Bondi, M. Due west., and Smith, Grand. Due east. (2014). Mild cerebral impairment: a concept and diagnostic entity in need of input from neuropsychology. J. Int. Neuropsychol. Soc. twenty, 129–134. doi: 10.1017/s1355617714000010

PubMed Abstract | CrossRef Full Text | Google Scholar

Chang, L., Andres, M., Sadino, J., Jiang, C. South., Nakama, H., Miller, E., et al. (2011). Impact of apolipoprotein E epsilon4 and HIV on knowledge and brain atrophy: antagonistic pleiotropy and premature brain aging. Neuroimage 58, 1017–1027. doi: x.1016/j.neuroimage.2011.07.010

PubMed Abstract | CrossRef Full Text | Google Scholar

Chang, L., Douet, V., Bloss, C., Lee, K., Pritchett, A., Jernigan, T. 50., et al. (2016). Gray affair maturation and cognition in children with different APOE ε genotypes. Neurology 87, 585–594.

Google Scholar

Chang, L., Lohaugen, G. C., Andres, T., Jiang, C. S., Douet, V., Tanizaki, North., et al. (2017). Adaptive working retentivity preparation improved brain office in human immunodeficiency virus-seropositive patients. Ann. Neurol. 81, 17–34. doi: 10.1002/ana.24805

PubMed Abstruse | CrossRef Full Text | Google Scholar

Chowdhury, R., Guitart-Masip, M., Bunzeck, N., Dolan, R. J., and Duzel, E. (2012). Dopamine modulates episodic retentiveness persistence in quondam age. J. Neurosci. 32, 14193–14204.

Google Scholar

Constantinidou, F., Zaganas, I., Papastefanakis, E., Kasselimis, D., Nidos, A., and Simos, P. One thousand. (2014). Age-related turn down in verbal learning is moderated by demographic factors, working memory capacity, and presence of amnestic balmy cognitive impairment. J. Int. Neuropsychol. Soc. 20, 822–835. doi: x.1017/s1355617714000678

PubMed Abstruse | CrossRef Full Text | Google Scholar

Doucet-Beaupre, H., Gilbert, C., Profes, M. S., Chabrat, A., Pacelli, C., Giguere, Northward., et al. (2016). Lmx1a and Lmx1b regulate mitochondrial functions and survival of developed midbrain dopaminergic neurons. Proc. Natl. Acad. Sci. U. S. A. 113, E4387–E4396.

Google Scholar

Flak, Chiliad. G., Hernes, S. S., Skranes, J., and Løhaugen, G. C. (2014). The Retention Aid report: protocol for a randomized controlled clinical trial evaluating the effect of computer-based working memory training in elderly patients with balmy cognitive damage (MCI). Trials fifteen:156.

Google Scholar

Flak, M. K., Hol, H. R., Hernes, S. S., Chang, 50., Engvig, A., Bjuland, K. J., et al. (2019). Adaptive Computerized Working Memory Training in Patients With Mild Cognitive Impairment. A Randomized Double-Bullheaded Active Controlled Trial. Front. Psychol. 10:807. doi: ten.3389/fpsyg.2019.00807

PubMed Abstract | CrossRef Full Text | Google Scholar

Goldman-Rakic, P. S. (1996a). Memory: recording experience in cells and circuits: multifariousness in memory research. Proc. Natl. Acad. Sci. U. South. A. 93, 13435–13437. doi: 10.1073/pnas.93.24.13435

PubMed Abstract | CrossRef Full Text | Google Scholar

Hollingshead, A. B., and Redlich, F. C. (2007). Social course and mental illness: a community study. Am. J. Publ. Health 97, 1756–1757.

Google Scholar

Huang, P., Fang, R., Li, B.-Y., and Chen, South.-D. (2016). Exercise-Related Changes of Networks in Aging and Mild Cognitive Impairment Brain. Front. Aging Neurosci. 8:47. doi: x.3389/fnagi.2016.00047

PubMed Abstract | CrossRef Full Text | Google Scholar

Jack, C. R. Jr., Therneau, T. Grand., Wiste, H. J., Weigand, South. D., Knopman, D. S., Lowe, V. J., et al. (2016). Transition rates between amyloid and neurodegeneration biomarker states and to dementia: a population-based, longitudinal accomplice report. Lancet Neurol. 15, 56–64. doi: 10.1016/s1474-4422(15)00323-3

CrossRef Total Text | Google Scholar

Jimenez-Bonilla, J. F., Quirce, R., De Arcocha-Torres, M., Martinez-Rodriguez, I., Martinez-Amador, N., Sanchez-Salmon, A., et al. (2019). A v-year longitudinal evaluation in patients with mild cognitive impairment by 11C-PIB PET/CT: a visual analysis. Nucl. Med. Commun. 40, 525–531. doi: 10.1097/mnm.0000000000001004

PubMed Abstract | CrossRef Full Text | Google Scholar

Karrer, T. M., Josef, A. K., Mata, R., Morris, E. D., and Samanez-Larkin, G. R. (2017). Reduced dopamine receptors and transporters but non synthesis capacity in normal aging adults: a meta-analysis. Neurobiol. Aging 57, 36–46. doi: 10.1016/j.neurobiolaging.2017.05.006

PubMed Abstract | CrossRef Total Text | Google Scholar

Li, Due south. C., Lindenberger, U., and Backman, L. (2010). Dopaminergic modulation of noesis across the life bridge. Neurosci. Biobehav. Rev. 34, 625–630. doi: 10.1016/j.neubiorev.2010.02.003

PubMed Abstract | CrossRef Full Text | Google Scholar

Matysiak, O., Kroemeke, A., and Brzezicka, A. (2019). Working Memory Chapters as a Predictor of Cognitive Training Efficacy in the Elderly Population. Forepart. Crumbling Neurosci. 11:126.

Google Scholar

Oltra-Cucarella, J., Ferrer-Cascales, R., Alegret, K., Gasparini, R., Diaz-Ortiz, L. M., Rios, R., et al. (2018). Risk of progression to Alzheimer'south affliction for different neuropsychological Balmy Cerebral Impairment subtypes: A hierarchical meta-analysis of longitudinal studies. Psychol. Aging 33, 1007–1021. doi: 10.1037/pag0000294

PubMed Abstruse | CrossRef Full Text | Google Scholar

Pantoni, L., Poggesi, A., Diciotti, S., Valenti, R., Orsolini, S., Della Rocca, E., et al. (2017). Effect of Attention Training in Mild Cognitive Impairment Patients with Subcortical Vascular Changes: The RehAtt Study. J. Alzheimers Dis. lx, 615–624. doi: ten.3233/jad-170428

PubMed Abstract | CrossRef Full Text | Google Scholar

Petersen, R. C., Smith, Chiliad. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., and Kokmen, Eastward. (1999). Mild cognitive impairment: clinical characterization and upshot. Archiv. Neurol. 56, 303–308. doi: ten.1001/archneur.56.3.303

PubMed Abstruse | CrossRef Total Text | Google Scholar

Petersen, R. C., Thomas, R. G., Aisen, P. Southward., Mohs, R. C., Carrillo, Yard. C., and Albert, Thou. S. (2017). Randomized controlled trials in mild cerebral impairment: Sources of variability. Neurology 88, 1751–1758. doi: 10.1212/wnl.0000000000003907

PubMed Abstract | CrossRef Total Text | Google Scholar

Putcha, D., and Tremont, G. (2016). Predictors of independence in instrumental activities of daily living: Amnestic versus nonamnestic MCI. J. Clin. Exp. Neuropsychol. 38, 991–1004. doi: x.1080/13803395.2016.1181716

PubMed Abstract | CrossRef Full Text | Google Scholar

Rog, L. A., and Fink, J. Westward. (2013). "Mild cognitive impairment and normal aging," in Handbook on the Neuropsychology of Aging and Dementia, (Netherland: Springer), 239–256. doi: 10.1007/978-one-4614-3106-0_16

CrossRef Full Text | Google Scholar

Rolstad, S., Pålsson, E., Ekman, C. J., Eriksson, E., Sellgren, C., and Landén, M. (2015). Polymorphisms of dopamine pathway genes NRG 1 and LMX 1A are associated with cognitive operation in bipolar disorder. Bipolar. Disor. 17, 859–868. doi: 10.1111/bdi.12347

PubMed Abstract | CrossRef Full Text | Google Scholar

Rozzini, L., Costardi, D., Chilovi, B. V., Franzoni, S., Trabucchi, Yard., and Padovani, A. (2007). Efficacy of cerebral rehabilitation in patients with mild cognitive harm treated with cholinesterase inhibitors. Int. J. Geriatr. Psych. 22, 356–360. doi: ten.1002/gps.1681

PubMed Abstract | CrossRef Full Text | Google Scholar

Salami, A., Garrett, D. D., Wahlin, A., Rieckmann, A., Papenberg, Thou., Karalija, North., et al. (2019). Dopamine D2/3 Binding Potential Modulates Neural Signatures of Working Memory in a Load-Dependent Fashion. J. Neurosci. 39, 537–547. doi: ten.1523/jneurosci.1493-18.2018

PubMed Abstract | CrossRef Full Text | Google Scholar

Saunders, N. L., and Summers, M. J. (2010). Attending and working retention deficits in mild cognitive impairment. J. Clin. Exp. Neuropsychol. 32, 350–357. doi: 10.1080/13803390903042379

PubMed Abstruse | CrossRef Full Text | Google Scholar

Scheller, E., Peter, J., Schumacher, L. V., Lahr, J., Mader, I., Kaller, C. P., et al. (2017). APOE moderates compensatory recruitment of neuronal resources during working retentiveness processing in good for you older adults. Neurobiol. Aging 56, 127–137. doi: 10.1016/j.neurobiolaging.2017.04.015

PubMed Abstract | CrossRef Full Text | Google Scholar

Sherman, D. S., Mauser, J., Nuno, Chiliad., and Sherzai, D. (2017). The Efficacy of Cerebral Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures. Neuropsychol. Rev. 27, 440–484. doi: ten.1007/s11065-017-9363-three

PubMed Abstract | CrossRef Full Text | Google Scholar

Simons, D. J., Kicking, Due west. R., Charness, N., Gathercole, Southward. East., Chabris, C. F., Hambrick, D. Z., et al. (2016). Exercise "brain-training" programs piece of work? Psychol. Sci. Publ. Interest 17, 103–186.

Google Scholar

Smith, Thou. E., Bohac, D. L., Waring, Due south. C., Kokmen, E., Tangalos, E. G., Ivnik, R. J., et al. (1998). Apolipoprotein E genotype influences cognitive 'phenotype' in patients with Alzheimer'south disease simply not in healthy control subjects. Neurology 50, 355–362. doi: 10.1212/wnl.50.ii.355

PubMed Abstract | CrossRef Full Text | Google Scholar

Söderqvist, Due south., Nutley, South. B., Peyrard-Janvid, M., Matsson, H., Humphreys, Thousand., Kere, J., et al. (2012). Dopamine, working memory, and grooming induced plasticity: Implications for developmental research. Devel. Psychol. 48:836. doi: ten.1037/a0026179

PubMed Abstract | CrossRef Full Text | Google Scholar

Talassi, E., Guerreschi, K., Feriani, M., Fedi, 5., Bianchetti, A., and Trabucchi, M. (2007). Effectiveness of a cognitive rehabilitation program in mild dementia (Md) and balmy cognitive harm (MCI): a case control report. Archiv. Gerontol. Geriatr. 44, 391–399. doi: 10.1016/j.archger.2007.01.055

PubMed Abstract | CrossRef Full Text | Google Scholar

Ten Kate, Grand., Barkhof, F., Boccardi, M., Visser, P. J., Jack, C. R. Jr., Lovblad, K. O., et al. (2017). Clinical validity of medial temporal cloudburst as a biomarker for Alzheimer's disease in the context of a structured five-stage development framework. Neurobiol. Crumbling 52, 167–182.eastward.

Google Scholar

Theendakara, V., Peters-Libeu, C. A., Bredesen, D. E., and Rao, R. Five. (2018). Transcriptional Effects of ApoE4: Relevance to Alzheimer's Illness. Mol. Neurobiol. 55, 5243–5254. doi: 10.1007/s12035-017-0757-2

PubMed Abstruse | CrossRef Full Text | Google Scholar

Tuminello, East. R., and Han>Han, S. D. (2011). The apolipoprotein e combative pleiotropy hypothesis: review and recommendations. Int. J. Alzheimer'south Dis. 2011:726197.

Google Scholar

van Dyck, C. H., Seibyl, J. P., Malison, R. T., Laruelle, M., Wallace, E., Zoghbi, S. S., et al. (1995). Historic period-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. J. Nucl. Med. 36, 1175–1181.

Google Scholar

Weuve, J., Barnes, L. L., Mendes, De Leon, C. F., Rajan, K. B., Brook, T., et al. (2018). Cerebral Crumbling in Black and White Americans: Cognition, Cognitive Decline, and Incidence of Alzheimer Disease Dementia. Epidemiology 29, 151–159. doi: ten.1097/ede.0000000000000747

PubMed Abstruse | CrossRef Full Text | Google Scholar

Winblad, B., Palmer, Thou., Kivipelto, Grand., Jelic, Five., Fratiglioni, L., Wahlund, L. O., et al. (2004). Mild cognitive impairment–beyond controversies, towards a consensus: written report of the International Working Group on Mild Cognitive Harm. J. Int. Med. 256, 240–246.

Google Scholar

Wirth, One thousand., Villeneuve, S., La Joie, R., Marks, Southward. M., and Jagust, W. J. (2014). Gene–surround interactions: lifetime cerebral activity, APOE genotype, and beta-amyloid brunt. J. Neurosci. 34, 8612–8617. doi: 10.1523/jneurosci.4612-13.2014

PubMed Abstruse | CrossRef Total Text | Google Scholar

Yang, H. L., Chu, H., Miao, Due north. F., Chang, P. C., Tseng, P., Chen, P., et al. (2019). The Construction and Evaluation of Executive Attending Training to Improve Selective Attending, Focused Attention, and Divided Attention for Older Adults With Mild Cognitive Harm: A Randomized Controlled Trial. Am. J. Geriatr. Psych. 27, 1257–1267. doi: 10.1016/j.jagp.2019.05.017

PubMed Abstruse | CrossRef Total Text | Google Scholar

Zhao, W., Huang, L., Li, Y., Zhang, Q., Chen, 10., Fu, W., et al. (2020). Evidence for the contribution of COMT gene Val158/108Met polymorphism (rs4680) to working memory training-related prefrontal plasticity. Brain Behav. 10:e01523.

Google Scholar

Zink, N., Bensmann, W., Arning, L., Beste, C., and Stock, A. K. (2019). Apolipoprotein epsilon4 is associated with better cerebral command allocation in healthy immature adults. Neuroimage 185, 274–285. doi: ten.1016/j.neuroimage.2018.ten.046

PubMed Abstruse | CrossRef Full Text | Google Scholar

lawrencemorty1992.blogspot.com

Source: https://www.frontiersin.org/articles/10.3389/fnagi.2021.624253/full